PhaseV
ML for Clinical Trial Optimization
Active
A
Startup
Tel Aviv-Yafo
Founded 2023-01
PhaseV develops a platform for adaptive clinical trial design and closed-loop execution, leveraging an intuitive user interface and flexible software architecture along with cutting-edge algorithms such as reinforcement learning and causal ML to support key clinical decisions at any point during the trial.
SectorHealth Tech & Life Sciences
StageA
Total raised$65.0M
Employees45
Founded2023-01
HQTel Aviv-Yafo
Confidence81
Sectors
Health Tech & Life SciencesDigital HealthcareClinical Workflow
Technology
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareLaboratories